Gyre Therapeutics, Inc. (GYRE)
8.02
+0.20
(+2.56%)
USD |
NASDAQ |
Feb 13, 16:00
8.03
+0.01
(+0.12%)
Pre-Market: 20:00
Gyre Therapeutics Market Cap : 772.59M for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 23.84M |
| Savara, Inc. | 1.139B |
| ADMA Biologics, Inc. | 3.829B |
| Viridian Therapeutics, Inc. | 2.663B |
| Nutex Health, Inc. | 705.14M |
Market Cap Related Metrics
| PE Ratio | 211.05 |
| PS Ratio | 7.376 |
| Price to Book Value | 7.580 |
| Price | 8.02 |
| Earnings Yield | 0.47% |
| Operating PE Ratio | 65.74 |
| Normalized PE Ratio | 405.05 |